CDH Investments Management
China's PE-backed Ubtech Robotics files for HK IPO
Ubtech Robotics, a China-based developer of service and humanoid robots valued at CNY 32bn (USD 4.4bn) in its most recent private funding round, has filed for a Hong Kong IPO.
The innovation game: China GPs play safe
China investors have abandoned their previous high-risk-high-return approach in favour of proven business models and profitability. Hotspots like autonomous driving, biotech, and SaaS are no exception
Deal focus: National team drives Hithium towards China IPO
Government and state-owned investors accounted for most, but not all, of Xiamen Hithium Energy Storage Technology’s USD 622m Series C, underlining where China’s strategic priorities lie
China's Hithium Energy Storage raises $622m
Xiamen Hithium Energy Storage Technology, a China-based battery manufacturer, has raised a Series C round of CNY 4.5bn (USD 622m) led by Beijing Financial Street Capital and China Life Insurance's private equity unit.
CDH, Oriza-backed CSI Solar enjoys strong Star Market debut
CSI Solar, a Chinese renewables business backed by CDH Investments and Oriza Holdings, increased 18% in value on its first day of trading following a CNY 6bn (USD 840m) IPO.
CDH leads $52m round for China's Boss Digital
The venture-growth unit of China's CDH Investments has led a CNY 370m (USD 52m) round for Boss Digital Procurement Technology Development, a subsidiary of Shenzhen-listed Fujian Boss Software.
South by Southeast: Asia’s next growth engine?
Grouping together markets based on growth and scale is a problematic with South Asia and Southeast Asia as it was with the BRIC economies. But to some extent, investors are buying into the story
Valuation stalemates stall SE Asia exits – M&A Forum
Private equity investors at the Mergermarket M&A Forum Southeast Asia sensed that something has to give in a deadlocked regional exit market, where the bid-ask divide could break in either direction.
Deal focus: China SaaS gets specific
Investors are gradually returning to China’s software-as-a-service space with an appetite for industry specialists rather than generalists. The CDH Investments-led Series B for 1Data is a case in point
CDH leads Series B for China RPA player 1data
1Data, a China-based robotic process automation (RPA) company, has raised close to CNY 200m (USD 29.2m) in Series B funding led by CDH Investments.
AVCJ Awards 2022: Deal of the Year – Small Cap: Well-Link
By taking computing to the cloud, graphics-as-a-service player Well-Link Technologies is looking to broaden access to video games and help power the metaverse. VC investors are keen to get involved
China cell therapy developer raises $75m
Iaso Biotherapeutics, a Chinese cell therapy developer focusing on oncology treatments, has raised nearly CNY 500m (USD 75m) in an extended Series C round.
China satellite developer Minospace raises $60m
Beijing-based satellite developer Minospace has raised nearly CNY400m (USD 59.6m) across a Series B round and a Series B extension.
2023 preview: Hard-tech
As China’s technology space has shifted toward more advanced domains of R&D, bubbles have formed and geopolitics have complicated investment. There is scope for some turnaround on these points
2023 preview: China macro
Private equity is eager to re-engage with China as a sudden post-pandemic re-opening reminds investors focused on the country to expect the unexpected. A weak global picture could spoil the party
China investors plan to step up activity – AVCJ Forum
Investors told the AVCJ Private Equity & Venture Forum that they are looking to accelerate their pace of investment in China next year despite economic and regulatory challenges.
Hong Kong vs Singapore: No zero-sum game
Pandemic-related restrictions have dented confidence in Hong Kong as a private equity hub, while Singapore is on a roll. But gains for one don’t necessarily translate into losses for the other
China's Giant Biogene trades up after $70m Hong Kong IPO
Giant Biogene, a China-based producer of skin treatments that use bioactive ingredients, gained nearly 10% on debut following a HKD 549.4m (USD 70m) Hong Kong IPO.
Deal focus: Well-Link aims to make gaming even more real
China’s Well-Link Technologies raised a Series B extension to support long-term investment and blue sky thinking around the role of real-time cloud rendering in gaming and metaverse applications
Temasek leads $40m Series B extension for China's Well-Link
Temasek Holdings has led a USD 40m Series B extension for Well-Link Technologies, a China-based provider of real-time cloud rendering solutions for game developers.
Deal focus: CDH plays Asia wellness card
CDH Investments turned The Better Health Company from a New Zealand-only player into a brand with regional recognition. COVID-19 proved a minor obstacle to an ultimately successful trade sale
CDH exits New Zealand supplements brand to Nestle
CDH Investments has agreed to sell New Zealand-based supplements manufacturer The Better Health Company (TBHC) to Nestlé Health Science for an undisclosed sum.
China fashion software platform Linctex raises $100m
Linctex Digital, a Shanghai-based design services platform for the fashion industry, has raised an extended pre-Series B round of nearly USD 100m from GL Ventures and CDH Investments.